Christopher Patusky - 16 Nov 2022 Form 4 Insider Report for UNITED THERAPEUTICS Corp (UTHR)

Role
Director
Signature
/s/ John S. Hess, Jr. under Power of Attorney
Issuer symbol
UTHR
Transactions as of
16 Nov 2022
Net transactions value
-$285,791
Form type
4
Filing time
18 Nov 2022, 15:30:12 UTC
Previous filing
18 Aug 2022
Next filing
04 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UTHR Common Stock Options Exercise $132,045 +1,500 +89% $88.03 3,180 16 Nov 2022 Direct F1
transaction UTHR Common Stock Disposed to Issuer $391,575 -1,500 -47% $261.05 1,680 16 Nov 2022 Direct F1
transaction UTHR Common Stock Sale $26,261 -100 -8.3% $262.61 1,100 17 Nov 2022 By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UTHR Share Tracking Award Options Exercise $0 -1,500 -13% $0.000000 10,000 16 Nov 2022 Common Stock 1,500 $88.03 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.
F2 Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.